Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,879,427 papers from all fields of science
Search
Sign In
Create Free Account
Z 103
Known as:
Z-103
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
polaprezinc
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Effect of Z-103 on TNB-induced colitis in rats.
T. Yoshikawa
,
T. Yamaguchi
,
+5 authors
M. Kondo
Digestion
1997
Corpus ID: 3306963
Z-103 is a chelate compound consisting of zinc ion and L-carnosine. In this study, we investigated the protective effect of Z-103…
Expand
1992
1992
[The gastric mucosal adhesiveness of Z-103 in rats with chronic ulcer].
M. Seiki
,
H. Aita
,
+7 authors
E. Tagashira
Nihon yakurigaku zasshi. Folia pharmacologica…
1992
Corpus ID: 45577808
The gastric mucosal adhesiveness of Z-103 in rats with acetic acid ulcer was studied macroscopically, histologically, and…
Expand
1992
1992
[Studies on the healing promoting action of Z-103 in chronic gastric ulcer models of rats].
H. Aita
,
T. Yoneta
,
+7 authors
E. Tagashira
Nihon yakurigaku zasshi. Folia pharmacologica…
1992
Corpus ID: 3047799
We studied the healing promoting action of Z-103 on the chronic gastric ulcer induced by acetic acid (AAU) or Fe-ascorbic acid…
Expand
1992
1992
[Effect of Z-103 on wound healing by dermal incision in guinea pigs].
M. Seiki
,
H. Aita
,
+6 authors
E. Tagashira
Nihon yakurigaku zasshi. Folia pharmacologica…
1992
Corpus ID: 25291003
We investigated the effects of Z-103, ZnSO4, L-carnosine and solcoseryl on wound healing by dermal incision in guinea pigs. The…
Expand
1992
1992
Protective effects of zinc L‐carnosine (Z‐103) on reserpine‐induced gastric ulceration in rats
C. Cho
1992
Corpus ID: 84422090
The present study examined the gastric protective effects of zinc L‐carnosine (Z‐103) in reserpinized rats. We also studied…
Expand
1991
1991
Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single…
H. Sano
,
S. Furuta
,
+5 authors
K. Matsuda
Arzneimittel-Forschung
1991
Corpus ID: 22524486
Studies on the absorption, distribution, metabolism and excretion of 14C-Z-103 and 65Zn-Z-103 (catena-(S)-[mu-[N alpha-(3…
Expand
1991
1991
Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3-aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 4th communication: disposition of zinc and amino acids in rats, dogs and monkeys.
S. Furuta
,
S. Toyama
,
M. Miwa
,
Y. Ikeda
,
H. Sano
,
K. Matsuda
Arzneimittel-Forschung
1991
Corpus ID: 34729983
The time course of the zinc plasma concentrations in rats, dogs and monkeys and the metabolic fate of L-carnosine were…
Expand
1990
1990
Antioxidative action of zinc-carnosine compound Z-103.
T. Tanigawa
,
T. Yoshikawa
,
+7 authors
N. Yoshida
Advances in Experimental Medicine and Biology
1990
Corpus ID: 19277329
The objective of the present study was to examine the anti-free radical action of Z-103 in vitro. Z-103 is a novel synthetic…
Expand
1990
1990
Zinc-carnosine chelate compound (Z-103) attenuates acute gastric mucosal injury induced by ischemia-reperfusion in rats.
Y. Naito
,
T. Yoshikawa
,
+6 authors
M. Kondo
Advances in Experimental Medicine and Biology
1990
Corpus ID: 32067643
A novel synthesized agent, zinc N-(3-aminopropionyl)-L-histidine (Z-103, Fig. 1), is a chelate compound that consists of zinc…
Expand
1989
1989
Effect of Z-103 on compound 48/80-induced gastric lesions in rats.
S. Ueki
,
M. Seiki
,
+4 authors
E. Tagashira
Scandinavian Journal of Gastroenterology…
1989
Corpus ID: 21641108
Z-103 (a novel anti-ulcer agent), given p.o. at doses of 30 and 100 mg/kg, significantly prevented gastric lesions induced by…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE